Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
NASEM Report Urges Tougher Oversight of 503A Pharmacies That Compound Topical Pain Creams
May 20 2020
•
By
Joanne S. Eglovitch
National Academies Study Calls for Better Oversight Of Compounding Pharmacies • Source: Shutterstock
More from Manufacturing
More from Compliance